Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

NCT05514548 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

265

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DRUG: INV-202
DRUG: Placebo

Sponsor

Inversago Pharma Inc.

Collaborators

[object Object]